The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

NCT00268840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms
Biliary Tract Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Gemcitabine

Sponsor

ARCAGY/ GINECO GROUP